首页
订购/客服:400-666-5481

H 89 2HCl

    
10mM in DMSO

H 89 2HCl

源叶(MedMol)
T93245 一键复制产品信息
130964-39-5
C20H20BrN3O2S·2HCl
519.28
(E)-N-(2-(4-bromocinnamylamino)ethyl)isoquinoline-5-sulfonamide dihydrochloride
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
T93245-1ml促销
10mM in DMSO

¥436.00 ¥392.00

9 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
靶点: IC50: 48 nM (protein kinase A)
体内研究: H-89 (0.2 mg/100g, i.p.) significantly increases seizure latency and threshold in PTZ-treated animals. H-89 (0.05, 0.2 mg/100 g, i.p.) prevents the epileptogenic activity of bucladesine (300 nM) with significant increase of seizure latency and seizure threshold.
参考文献: 1. Chijiwa T, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990 Mar 25;265(9):5267-72.
2. Blazev R, et al. Effects of the PKA inhibitor H-89 on excitation-contraction coupling in skinned and intact skeletal muscle fibres. J Muscle Res Cell Motil. 2001;22(3):277-86.
3. Hosseini-Zare MS, et al. Effects of BL-191 and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice. Eur J Pharmacol. 2011 Nov 30;670(2-3):464-70.
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.926 ml 9.629 ml 19.257 ml
5 mM 0.385 ml 1.926 ml 3.851 ml
10 mM 0.193 ml 0.963 ml 1.926 ml
50 mM 0.039 ml 0.193 ml 0.385 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×